BERNINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 9.496
EU - Europa 7.154
AS - Asia 4.877
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 6
OC - Oceania 5
Totale 21.575
Nazione #
US - Stati Uniti d'America 9.328
CN - Cina 2.827
IE - Irlanda 1.633
SG - Singapore 1.424
FI - Finlandia 1.195
SE - Svezia 1.139
DE - Germania 917
UA - Ucraina 884
IT - Italia 832
TR - Turchia 504
CA - Canada 163
FR - Francia 143
GB - Regno Unito 130
AT - Austria 83
BE - Belgio 47
CZ - Repubblica Ceca 44
IN - India 43
NL - Olanda 33
HK - Hong Kong 22
ES - Italia 17
CI - Costa d'Avorio 15
EU - Europa 15
IL - Israele 11
JP - Giappone 11
PL - Polonia 10
RO - Romania 10
IR - Iran 9
ID - Indonesia 7
TW - Taiwan 7
HU - Ungheria 6
AU - Australia 4
LU - Lussemburgo 4
MX - Messico 4
PT - Portogallo 4
RS - Serbia 4
BR - Brasile 3
CH - Svizzera 3
CM - Camerun 3
LT - Lituania 3
BG - Bulgaria 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KR - Corea 2
KZ - Kazakistan 2
NG - Nigeria 2
PK - Pakistan 2
SA - Arabia Saudita 2
AR - Argentina 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 21.575
Città #
Dublin 1.633
Chandler 1.550
Singapore 1.128
Jacksonville 1.114
Santa Clara 828
Beijing 754
Nanjing 507
Ashburn 504
Dearborn 498
Boardman 497
Izmir 484
Princeton 388
Ann Arbor 376
Wilmington 260
Parma 256
New York 237
San Mateo 234
Bremen 230
Shenyang 152
Shanghai 147
Toronto 143
Nanchang 136
Hebei 134
Helsinki 130
Kunming 116
Hefei 104
Jinan 94
Des Moines 91
Seattle 85
Jiaxing 77
Vienna 77
Tianjin 76
Woodbridge 74
Grafing 73
Changsha 62
Marseille 59
Norwalk 57
Los Angeles 53
Guangzhou 51
Brussels 44
Zhengzhou 40
Chicago 39
Houston 35
Pune 34
Milan 31
Fremont 29
Brno 28
Munich 28
Hangzhou 26
Rome 25
Taiyuan 22
Düsseldorf 21
Bologna 20
Haikou 18
Dallas 17
Ningbo 17
Rockville 17
Abidjan 15
Modena 15
Chengdu 13
Kocaeli 13
Taizhou 13
Auburn Hills 12
Borås 12
Falls Church 12
Hong Kong 12
Bari 11
Fuzhou 11
Xian 11
Frankfurt am Main 10
Shenzhen 10
Tel Aviv 10
Madrid 9
Simi Valley 9
Warsaw 9
Washington 8
Florence 7
London 7
Paris 7
Redmond 7
Redwood City 7
San Giuliano Milanese 7
Ardea 6
Budapest 6
Fairfield 6
Huizen 6
Istanbul 6
Naples 6
Palermo 6
Piacenza 6
Sant'ilario D'enza 6
Scottsdale 6
Shaoxing 6
Turin 6
Villaromagnano 6
Wenzhou 6
Wuhan 6
Abbiategrasso 5
Albignasego 5
Castello Molina di Fiemme 5
Totale 14.322
Nome #
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 154
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 135
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 135
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 114
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 110
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 100
New MDR1 inhibitors for overcoming multidrug resistance 100
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 98
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 97
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 95
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 92
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 92
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 91
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 91
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 91
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 90
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 90
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 90
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 89
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 89
Role of Apolipoprotein E in cellular cholesterol efflux 88
Antiatherogenic effects of ellagic acid and urolithins in vitro 88
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 88
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 88
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 87
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 86
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 86
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 86
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 85
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 85
Natural anti-endothelial cell antibodies (AECA) 84
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 84
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 84
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 83
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 83
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 83
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 82
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 81
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 81
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 81
Lacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 80
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 80
Cellular toxicity of 2,2'N-dicarboxamidodiphenylsulphides with high antimicrobal activity 80
Serum cholesterol efflux capacity and endothelial function in hyperalfalipoproteinemic subjects 80
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 79
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 79
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 79
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 79
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 79
CAPACITA' DI EFFLUSSO DI COLESTEROLO (CEC): INDICE DI ATTIVITA' ATEROPROTETTIVA DELLE HDL? Cholesterol efflux capacity (CEC): an index of atheroprotective activity of HDL? 78
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 77
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 77
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 77
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 77
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 76
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 76
Immunoglobulins G inhibit endothelial activation induced by atherogenic stimuli 75
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 75
THE THIENOTRIAZOLODIAZEPINE RO 11-1464 INCREASES PLASMA APOA-I AND PROMOTES REVERSE CHOLESTEROL TRANSPORT AND FECAL STEROL EXCRETION IN HUMAN APOA-I TRANSGENIC MICE 75
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 75
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 75
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 74
L’ALCALOIDE BERBERINA RIDUCE L’ATTIVITÀ DI ABCA1 NEI MACROFAGI CON UN EFFETTO TRASCRIZIONALE 74
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 74
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 74
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 74
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 73
Fu5AH express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 73
Natural anti-endothelial cell antibodies (AECA) 73
Effetto della mutazione dell’enzima LCAT sull’efflusso cellulare di colesterolo 73
Rupture of the Atherosclerotic Plaque. Does a Good Animal Model Exist? 72
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAI milano carriers 72
Evaluation of HDL cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics 72
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 72
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 72
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 72
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 71
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 71
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 71
Pleiotropic Antiatherosclerotic Effect of Lipophilic Calcium Antagonists in Macrophages 70
Cholesterol efflux and reverse cholesterol transport 70
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 70
Modulation of cholesterol efflux in human THP-I macrophages 69
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 69
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 69
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 69
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 69
Razionale farmacologico e prove di efficacia della combinazione di più nutraceutici ad azione ipocolesterolemizzante 69
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 68
Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli 68
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 68
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 68
Cholesterol efflux from oxidized LDL loaded macrophages 68
Effect of HDL composition and size on cellular cholesterol efflux 68
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 68
Device for ocular administration of fluids 68
New insights into the pharmacodynamic and pharmacokinetic properties of statins 67
La Lercanidipina riduce la tossicita' cellulare indotta dall'accumulo di colesterolo libero 67
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 67
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 67
Totale 8.107
Categoria #
all - tutte 87.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.989 0 0 0 0 0 352 449 73 366 381 111 257
2020/20211.973 31 252 155 35 249 57 225 51 498 59 305 56
2021/20221.594 46 17 13 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20252.971 137 454 533 428 762 657 0 0 0 0 0 0
Totale 22.111